Arthur Y Hung

Summary

Affiliation: Oregon Health and Science University
Country: USA

Publications

  1. ncbi request reprint Radiation therapy for gastrointestinal cancer
    Arthur Y Hung
    Department of Radiation Oncology, Oregon Health and Science University, Portland, OR 97239 3098, USA
    Hematol Oncol Clin North Am 20:287-320. 2006
  2. doi request reprint Minimal benefit of an endorectal balloon for prostate immobilization as verified by daily localization
    Arthur Y Hung
    Department of Radiation Oncology, Oregon Health and Science University, Portland, OR 97239 3098, USA
    Med Dosim 36:195-9. 2011
  3. doi request reprint Contemporary management of high-risk localized prostate cancer
    Mark Garzotto
    Division of Urology, Department of Surgery, and the Department of Radiation Medicine, Oregon Health and Science University, Portland Veterans Administration Medical Center, Portland, OR, 97239, USA
    Curr Urol Rep 11:159-64. 2010
  4. doi request reprint Advances in the multimodality management of high-risk prostate cancer
    Mark Garzotto
    Department of Urology, Portland Veterans Administration Medical Center, Oregon Health and Science University, Portland, OR 97239, USA
    Surg Oncol Clin N Am 22:375-94. 2013
  5. doi request reprint Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter- and intrafraction motion
    James A Tanyi
    Department of Radiation Medicine, Oregon Health and Science University, Portland, OR 97239 3098, USA
    Int J Radiat Oncol Biol Phys 78:1579-85. 2010
  6. doi request reprint Salvage intensity-modulated radiation therapy for locally recurrent prostate cancer after cryotherapy
    Mehee Choi
    Department of Radiation Oncology, Robert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA
    Clin Genitourin Cancer 11:85-8. 2013
  7. doi request reprint Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas
    Christopher W Ryan
    Department of Medicine, Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR 97239, USA
    Cancer 112:2432-9. 2008
  8. doi request reprint Technological advances in radiation therapy for prostate cancer
    Mehee Choi
    Department of Radiation Medicine, KPV4, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR, 97239 3098, USA
    Curr Urol Rep 11:172-9. 2010
  9. ncbi request reprint Stage T1c prostate cancer: a heterogeneous category with widely varying prognosis
    Arthur Y Hung
    Department of Radiation Oncology, The University of Texas, M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer J 8:440-4. 2002

Detail Information

Publications9

  1. ncbi request reprint Radiation therapy for gastrointestinal cancer
    Arthur Y Hung
    Department of Radiation Oncology, Oregon Health and Science University, Portland, OR 97239 3098, USA
    Hematol Oncol Clin North Am 20:287-320. 2006
    ..Further scientific investigation is needed to establish the optimal role of radiation and to better define its integration with novel systemic and biologic modalities...
  2. doi request reprint Minimal benefit of an endorectal balloon for prostate immobilization as verified by daily localization
    Arthur Y Hung
    Department of Radiation Oncology, Oregon Health and Science University, Portland, OR 97239 3098, USA
    Med Dosim 36:195-9. 2011
    ..Day-to-day variability of the position of the prostate is reduced in all dimensions with the water-filled ERB, but not significantly statistically. Use of the water-filled ERB did not obviate performing some form of image guidance daily...
  3. doi request reprint Contemporary management of high-risk localized prostate cancer
    Mark Garzotto
    Division of Urology, Department of Surgery, and the Department of Radiation Medicine, Oregon Health and Science University, Portland Veterans Administration Medical Center, Portland, OR, 97239, USA
    Curr Urol Rep 11:159-64. 2010
    ..It is likely that the development of effective strategies based on understanding prostate tumor biology will lead to significant advances in the treatment of this disease...
  4. doi request reprint Advances in the multimodality management of high-risk prostate cancer
    Mark Garzotto
    Department of Urology, Portland Veterans Administration Medical Center, Oregon Health and Science University, Portland, OR 97239, USA
    Surg Oncol Clin N Am 22:375-94. 2013
    ..The combination of early cancer detection and technical improvements in local treatment has led to a reduction in disease burden and an increase in cancer survivorship. However, treatment failure remains common among high-risk cases...
  5. doi request reprint Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter- and intrafraction motion
    James A Tanyi
    Department of Radiation Medicine, Oregon Health and Science University, Portland, OR 97239 3098, USA
    Int J Radiat Oncol Biol Phys 78:1579-85. 2010
    ....
  6. doi request reprint Salvage intensity-modulated radiation therapy for locally recurrent prostate cancer after cryotherapy
    Mehee Choi
    Department of Radiation Oncology, Robert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA
    Clin Genitourin Cancer 11:85-8. 2013
    ..To summarize our results of intensity-modulated radiation therapy (IMRT) for prostate adenocarcinoma after cryotherapy failure...
  7. doi request reprint Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas
    Christopher W Ryan
    Department of Medicine, Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR 97239, USA
    Cancer 112:2432-9. 2008
    ..The authors studied a dose-intense regimen of epirubicin and ifosfamide with hypofractionated preoperative radiotherapy for high-risk soft tissue sarcomas. The primary objective was estimation of the rate of >or=95% pathologic necrosis...
  8. doi request reprint Technological advances in radiation therapy for prostate cancer
    Mehee Choi
    Department of Radiation Medicine, KPV4, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR, 97239 3098, USA
    Curr Urol Rep 11:172-9. 2010
    ..This review summarizes the recent technical advances made in radiation dose delivery, including target volume definition, treatment planning, treatment delivery methods, and positional verification methods during RT...
  9. ncbi request reprint Stage T1c prostate cancer: a heterogeneous category with widely varying prognosis
    Arthur Y Hung
    Department of Radiation Oncology, The University of Texas, M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer J 8:440-4. 2002
    ....